Real-world data can help expedite drug approvals for serious diseases with few options
Augmenting and extending trials with real-world data
Linking real-world data to registration trials as a standard for validating drug effectiveness could be beneficial in many situations. It could help determine if cancer drugs approved using surrogate endpoints like complete pathological response or progression-free survival actually increase overall survival.
Real-world data can help expedite the drug approval process - STAT (statnews.com)